- 연구개발
HOME- 파이프라인
| Product | Function | POC | Preclinical | Phase I | Phase II |
|---|---|---|---|---|---|
| LB101 | MDR (Multi drug resistance) | ||||
| LB102 | MDR (Multi drug resistance) | ||||
| LB103 | Anti-inflammatory, DMD (Duchenne Muscular Dystrophy), Anti-wrinkle |
| Product | Function | POC | Preclinical | Phase I | Phase II |
|---|---|---|---|---|---|
| LB101 | MDR (Multi drug resistance) | ||||
| LB102 | MDR (Multi drug resistance) | ||||
| LB103 | Anti-inflammatory, DMD (Duchenne Muscular Dystrophy), Anti-wrinkle |